ArticleJournal of translational medicine2026
Gut microbiota-associated leucine elevation promotes cold-induced atherosclerotic plaque formation and instability.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundEnvironmental factors such as cold exposure have been increasingly recognized as contributors to atherosclerosis progression, yet the underlying mechanisms linking environmental stress to vascular pathology remain incompletely understood. In particular, the role of the gut microbiota and microbiota-associated metabolites in cold-induced atherosclerosis has not been fully elucidated.
methodsA cold exposure model was established in ApoE⁻/⁻ mice fed a Western diet. Integrated multi-omics analyses were combined with fecal microbiota transplantation (FMT) and mechanistic cellular assays to investigate gut microbiota remodeling, metabolic alterations, and immune regulation during cold-induced atherosclerosis.
resultsIn this study, we demonstrate that cold exposure accelerates atherosclerotic plaque growth and instability in parallel with pronounced gut microbiota dysbiosis and alterations in host metabolic profiles. FMT combined with metabolomic analyses showed that cold-associated gut microbiota is closely associated with elevated circulating leucine levels, suggesting that cold-induced microbial remodeling may participate in this process by modulating host systemic leucine availability. Mechanistically, increased leucine suppressed the Zic family member 2 (Zic2) in macrophages, leading to reduced expression of growth arrest-specific 6 (Gas6), a key mediator of efferocytosis. Impaired Gas6-dependent efferocytosis resulted in defective clearance of apoptotic cells, heightened vascular inflammation, and increased plaque instability. Importantly, supplementation with Lactobacillus johnsonii, a commensal bacterium depleted under cold exposure, normalized circulating leucine levels, restored Zic2-Gas6 signaling, enhanced macrophage efferocytosis, and attenuated atherosclerotic plaque progression. Conversely, leucine supplementation recapitulated the effects of cold exposure on plaque development and instability.
conclusionsCollectively, these findings identify a previously unrecognized cold-microbiota-leucine-Zic2-Gas6-efferocytosis axis that links environmental stress to atherosclerosis progression. Targeting gut microbial regulation of host systemic leucine levels, including L. johnsonii-based interventions, may represent a promising therapeutic strategy for preventing cold-induced atherosclerotic cardiovascular disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.